Liu Beijia, Liu Zhengzheng, Gui Qian, Lin Ying, Huang Guiyu, Lyu Jianxia, Weng Niannian, Tang Xiaoli
School of Medicine, University of Electronic Science and Technology of China, Sichuan Cancer Hospital, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Department of Radiation Oncology, Sichuan Cancer Hospital, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
BMC Cancer. 2024 Dec 2;24(1):1483. doi: 10.1186/s12885-024-13237-y.
Cancer remains a leading cause of death globally, with patients frequently experiencing malnutrition due to both the disease and its treatment, which negatively affects their quality of life and treatment outcomes. Oral nutritional supplements (ONS) provide a noninvasive solution to improve nutritional status, but poor patient adherence limits their effectiveness. Studies on ONS adherence vary in their definitions and assessment tools, creating inconsistencies. A scoping review is essential to synthesize these studies and establish a foundation for future research and clinical practice.
We systematically searched six databases, including Web of Science, PubMed, and Scopus, up to August 2024. Our criteria focused on oncology patients, ONS interventions, and outcomes related to adherence definitions, assessment methods, and adherence rates.
37 studies from 2005 to 2024 met the inclusion criteria. Definitions of ONS adherence and assessment methods vary widely, with the most common definition being the ratio of actual intake to the recommended amount. The assessment tools included self-reported ONS diaries, and MMAS scores, among others. Adherence rates also vary significantly, with some studies reporting a decline in adherence over time.
The lack of standardized definitions and assessment methods for ONS adherence across studies hinders comparability. Future research should focus on developing standardized, comprehensive adherence assessment tools that incorporate both quantitative and qualitative data. This would allow for a better understanding of adherence factors and enable more targeted interventions to improve long-term adherence in cancer patients.
癌症仍然是全球主要的死亡原因,患者常常因疾病本身及其治疗而出现营养不良,这对他们的生活质量和治疗结果产生负面影响。口服营养补充剂(ONS)为改善营养状况提供了一种非侵入性解决方案,但患者依从性差限制了其有效性。关于ONS依从性的研究在定义和评估工具方面各不相同,造成了不一致性。进行一项范围综述对于综合这些研究并为未来研究和临床实践奠定基础至关重要。
我们系统检索了截至2024年8月的六个数据库,包括科学网、PubMed和Scopus。我们的纳入标准侧重于肿瘤患者、ONS干预措施以及与依从性定义、评估方法和依从率相关的结果。
2005年至2024年的37项研究符合纳入标准。ONS依从性的定义和评估方法差异很大,最常见的定义是实际摄入量与推荐量的比率。评估工具包括自我报告的ONS日记和MMAS评分等。依从率也有显著差异,一些研究报告称依从性会随时间下降。
各项研究中ONS依从性缺乏标准化的定义和评估方法,这妨碍了可比性。未来的研究应专注于开发标准化、全面的依从性评估工具,纳入定量和定性数据。这将有助于更好地理解依从性因素,并使干预措施更具针对性,以提高癌症患者的长期依从性。